| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| PROFESSIONAL FEES | 5,500 | 2,750 | 2,750 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 2,054 SHS ROCKET PHARMACEUTICALS | 21,542 | 112,641 |
| 9,200 SHS ENTERPRISE PRODUCT PARTNERS | 132,027 | 180,228 |
| 1,500 SHS DICERNA PHARMACEUTICALS | 21,449 | 33,045 |
| Description | Amount |
|---|---|
| NONDEDUCTIBLE EXPENSE | 11 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| BANK FEES | 330 | 330 | 0 | |
| NY DEPT OF LAW | 250 | 0 | 0 | |
| INVESTMENT INTEREST EXPENSE | 30 | 30 | 0 | |
| THRU ENERGY TRANSFER LP | 13,084 | 13,084 | 0 |
| Description | Amount |
|---|---|
| UNREALIZED GAIN | 11,015 |